--- Page 0 ---
16271 Federal Register / Vol. 66, No. 57 / Friday, March 23, 2001 / Notices Activities, National Cancer Institute, National Institutes of Health, 6116 ExecutiveBoulevard, 8th Floor, Room 8050, Bethesda,MD 20852 –8328, (301) 496 –7930, mg85x@nih,gov. This notice is being published less than 15 days prior to the meeting due to the timinglimitations imposed by the review andfunding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction;93.393, Cancer Cause and PreventionResearch; 93.394, Cancer Detection andDiagnosis Research; 93.395, CancerTreatment Research; 93.396, Cancer BiologyResearch; 93.397, Cancer Centers Support;93.398, Cancer Research Manpower; 93.399,Center Control, National Institutes of Health,HHS) Dated: March 15, 2001. LaVerne Y. Stringfield,Director, Office of Federal Advisory Committee Policy. [FR Doc. 01 –7213 Filed 3 –22–01; 8:45 am] BILLING CODE 4140 –01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of HealthNational Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, asamended (5 U.S.C. Appendix 2), noticeis hereby given of the followingmeeting. The meeting will be closed to the public in accordance with theprovisions set forth in sections552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,as amended. The grant applications andthe discussions could discloseconfidential trade secrets or commercialproperty such as patentable material,and personal information concerningindividuals associated with the grantapplications, the disclosure of whichwould constitute a clearly unwarrantedinvasion of personal privacy. Name of Committee: National Cancer Institute Initial Review Group, SubcommitteeE—Cancer Epidemiology, Prevention & Control. Date: April 4 –6, 2001. Time: 7 a.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn —Georgetown, 2101 Wisconsin Avenue, NW., Washington, DC20007. Contact Person: Mary C Fletcher, PhD, Scientific Review Administrator, GrantsReview Branch, Division of ExtramuralActivities, National Cancer Institute, NationalInstitutes of Health, 6116 ExecutiveBoulevard, Room 8115, Bethesda, MD 20892 – This notice is being published less than 15 days prior to the meeting due to the timinglimitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction;93.393, Cancer Cause and PreventionResearch; 93.394, Cancer Detection andDiagnosis Research; 93.395, CancerTreatment Research; 93.396, Cancer BiologyResearch; 93.397, Cancer Centers Support;93.398, Cancer Research Manpower; 93.399,Cancer Control, National Institutes of Health,HHD) Dated: March 15, 2001. LaVerne Y. Stringfield,Director, Office of Federal Advisory Committee Policy. [FR Doc. 01 –7214 Filed 3 –22–01; 8:45 am] BILLING CODE 4140 –01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of HealthNational Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, asamended (5 U.S.C. Appendix 2), noticeis hereby given of the followingmeeting. The meeting will be closed to the public in accordance with theprovisions set forth in sections552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,as amended. The grant applications andthe discussions could discloseconfidential trade secrets or commercialproperty such as patentable material,and personal information concerningindividuals associated with the grantapplications, the disclosure of whichwould constitute a clearly unwarrantedinvasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, FlexibleSystem to Advance Innovative Research forCancer Drug Discovery by Small Business. Date: April 19, 2001. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, 6130 Executive Boulevard, EPN/Conference J,Rockville, MD 20852. Contact Person: Timothy C. Meeker, MD, Scientific Review Administrator, SpecialReview and Resources Branch, Division ofExtramural Activities, National CancerInstitute, 6116 Executive Boulevard, Room8088, Rockville, MD 20852, 301/594 –1279, meekert@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction;93.393, Cancer Cause and PreventionResearch; 93.394, Cancer Detection andDiagnosis Research; 93.395, CancerTreatment Research; 93.396, Cancer BiologyResearch; 93.397, Cancer Centers Support;93.398, Cancer Research Manpower; 93.399,Cancer Control, National Institutes of Health, HHS) Dated: March 15, 2001. LaVerne Y. Stringfield,Director, Office of Federal Advisory Committee Policy. [FR Doc. 01 –7215 Filed 3 –22–01; 8:45 am] BILLING CODE 4140 –01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of HealthNational Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, asamended (5 U.S.C. Appendix 2), noticeis hereby given of the followingmeeting. The meeting will be closed to the public in accordance with theprovisions set forth in sections552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,as amended. The grant applications andthe discussions could discloseconfidential trade secrets or commercialproperty such as patentable material,and personal information concerningindividuals associated with the grantapplications, the disclosure of whichwould constitute a clearly unwarrantedinvasion of personal privacy. Name of Committee: National Cancer Institute Initial Review Group, SubcommitteeC—Basic & Preclinical Basic and Preclinical Studies. Date: April 10 –11, 2001. Time: 7:30 pm to 6 pm. Agenda: To review and evaluate grant applications. Place: Georgetown Holiday Inn, 2101 Wisconsin Avenue, NW., Washington, DC20007. Contact Person: Michael B. Small, PhD, Scientific Review Administrator, GrantsReview Branch, Division of ExtramuralActivities, National Cancer Institute, NationalInstitutes of Health, 6116 ExecutiveBoulevard, Room 8040, Bethesda, MD 20892,301/402 –0996. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction;93.393, Cancer Cause and PreventionResearch; 93.394, Cancer Detection andDiagnosis Research; 93.395, CancerTreatment Research; 93.396, Cancer BiologyResearch; 93.397, Cancer Centers Support;93.398, Cancer Research Manpower; 93.399,Cancer Control, National Institutes of Health,HHS) Dated: March 15, 2001. LaVerne Y. Stringfield,Director, Office of Federal Advisory Committee Policy. [FR Doc. 01 –7216 Filed 3 –22–01; 8:45 am] BILLING CODE 4140 –01–M VerDate 11<MAY>2000 19:20 Mar 22, 2001 Jkt 194001 PO 00000 Frm 00100 Fmt 4703 Sfmt 4703 E:\FR\FM\23MRN1.SGM pfrm01 PsN: 23MRN1